Difference between revisions of "Part:BBa K1725002"

 
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K1725002 short</partinfo>
 
<partinfo>BBa_K1725002 short</partinfo>
 
The promoter is on normally, and off when the PhlF repressor (K1725041) is bound to it. We measured the strength of the promoter with GFP and two different ribosome binding sites (B0032 and B0034), and compared to R0040 and K1725020.
 
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 11: Line 8:
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K1725002 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K1725002 SequenceAndFeatures</partinfo>
 +
 +
This reporter was used to characterise the promoter <bbpart>BBa_K1725000</bbpart> which was used to drive expression of GFP with two different Ribosome Binding Sites, <bbpart>BBa_B0032</bbpart> in E5501, for this part, and <bbpart>BBa_B0034</bbpart> in I13500. PphlF is a stronger promoter than pL-tet (<bbpart>BBa_R0040</bbpart> or PsrpR (<bbpart>BBa_K1725020</bbpart>). (figure 1) PhlF (<bbpart>BBa_K1725040</bbpart>) gave 83-fold repression of GFP expression from PphlF, whereas the control, TetR (<bbpart>BBa_C0040</bbpart>), gave only 33-fold repression of pL-tet. (figure 2)
 +
 +
 +
https://static.igem.org/mediawiki/parts/e/ee/Glasgow_2015_Promoter_Strength_Graph.png
 +
 +
<b>Figure 1 Relative Promoter Strength. BioBricks: K1725082 (pL-tet driving GFP expression with B0034), E5504 (pL-tet driving GFP expression with B0032), K1725001 (PphlF driving GFP expression with B0034), and K1725002 (PphlF driving GFP expression with B0032). Mean and standard deviation of replicates were calculated to give value and error bars, and normalised against a negative control.</b>
 +
 +
 +
https://static.igem.org/mediawiki/parts/7/78/Glasgow_2015_Fold_Repression_Graph.png
 +
 +
<b>Figure 2 Fold Repression. BioBricks: K1725082 (pL-tet driving GFP expression), K1725031 (pL-lac driving TetR expression), K1725001 (PphlF driving GFP expression), and K1725042 (pL-lac driving PhlF expression). Repressor protein expression induced with 100μM IPTG. Mean and standard deviation of replicates were calculated to give value and error bars, and normalised against a negative control.</b>
 +
 +
 +
  
  

Latest revision as of 19:27, 20 September 2015

PhlF repressible promoter + weak RBS + GFP

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 719

This reporter was used to characterise the promoter BBa_K1725000 which was used to drive expression of GFP with two different Ribosome Binding Sites, BBa_B0032 in E5501, for this part, and BBa_B0034 in I13500. PphlF is a stronger promoter than pL-tet (BBa_R0040 or PsrpR (BBa_K1725020). (figure 1) PhlF (BBa_K1725040) gave 83-fold repression of GFP expression from PphlF, whereas the control, TetR (BBa_C0040), gave only 33-fold repression of pL-tet. (figure 2)


Glasgow_2015_Promoter_Strength_Graph.png

Figure 1 Relative Promoter Strength. BioBricks: K1725082 (pL-tet driving GFP expression with B0034), E5504 (pL-tet driving GFP expression with B0032), K1725001 (PphlF driving GFP expression with B0034), and K1725002 (PphlF driving GFP expression with B0032). Mean and standard deviation of replicates were calculated to give value and error bars, and normalised against a negative control.


Glasgow_2015_Fold_Repression_Graph.png

Figure 2 Fold Repression. BioBricks: K1725082 (pL-tet driving GFP expression), K1725031 (pL-lac driving TetR expression), K1725001 (PphlF driving GFP expression), and K1725042 (pL-lac driving PhlF expression). Repressor protein expression induced with 100μM IPTG. Mean and standard deviation of replicates were calculated to give value and error bars, and normalised against a negative control.